The Virtual-Based Opioid Treatment for Veterans Act directs the Department of Veterans Affairs to launch a two-year pilot program aimed at expanding access to virtual opioid treatment for enrolled veterans who face barriers to in-person care. This initiative requires the VA to conduct outreach, build referral networks, and coordinate with other federal agencies to connect veterans with telehealth programs that combine medication and counseling in a single visit. The bill also mandates a study on treatment barriers and requires annual reports to Congress on the program's progress until the opioid crisis is no longer considered a public health emergency.
The Turn the Tide Act primarily increases federal funding for substance use disorder treatment, prevention, and recovery services, directing billions of dollars to states, tribes, and local organizations for the years 2027 through 2030. Key provisions include expanding Medicaid coverage for mental health and behavioral health services, removing insurance barriers to medication-assisted treatment, and limiting cost-sharing requirements for opioid overdose reversal medications. The bill also establishes new grant programs to support recovery housing, train first responders, and assist law enforcement with mental health and wellness initiatives. Additionally, it targets funding toward states with the highest rates of drug overdose deaths and extends existing waivers to improve Medicaid delivery systems in those areas.
The Expanding Opportunities for Recovery Act of 2026 directs federal funding to states to improve access to opioid addiction treatment for individuals who lack health insurance or face coverage barriers. These grants must be managed by state substance abuse agencies and used to provide evidence-based services, such as medication-assisted treatment, based on medical recommendations. The legislation explicitly limits grant funds to cover no more than 60 consecutive days of treatment per person and requires states to report data on treatment outcomes and usage. Additionally, the bill mandates that the federal government evaluate the program's effectiveness and share results publicly while offering technical assistance to participating states.
The Modernizing Opioid Treatment Access Act 2.0 of 2026 allows specific addiction medicine specialists to prescribe methadone for opioid use disorder to be dispensed directly through pharmacies, rather than requiring patients to attend traditional treatment clinics. This change permits these qualified doctors to use telemedicine for patient care and requires that the methadone be in a liquid or dispersible tablet form. While the bill maintains existing clinic-based treatment options, it streamlines access by removing the need for pharmacies to obtain separate registrations to dispense the medication. The law also mandates that patients sign informed consent forms explaining how privacy rules differ between clinic and pharmacy settings, and it requires the Drug Enforcement Administration to report on the program's progress to Congress every year.
This bill establishes the Native Children's Commission Implementation Act of 2026 to improve health, education, and safety outcomes for Native American, Alaska Native, and Native Hawaiian children and families. It creates several new advisory committees within federal agencies to provide ongoing guidance on issues such as juvenile justice, maternal health, substance abuse, and environmental protection. The legislation also authorizes grants and pilot programs to expand access to mental health services, increase the perinatal workforce, support Native language schools, and provide housing assistance for homeless youth and families. Additionally, it modifies existing laws to allow Tribes greater flexibility in administering nutrition and child care programs while ensuring they receive adequate funding for administrative costs.
The Maternal Access to Treatment Act of 2026 requires the Bureau of Prisons to offer medication-assisted treatment to pregnant inmates addicted to opioids. This provision ensures that pregnant women in federal custody have access to medical care for opioid use disorder, unless they explicitly choose to decline the treatment while remaining mentally competent. The bill directly affects the Bureau of Prisons and pregnant incarcerated women by mandating the availability of this specific medical service.
This bill creates a five-year pilot program to provide grants to states and local governments for expanding Forensic Assertive Community Treatment teams. These specialized teams offer intensive, round-the-clock support including mental health care, addiction treatment, and housing assistance to individuals with serious mental illness who are involved with the criminal justice system. The program requires teams to include a mix of psychiatrists, employment specialists, criminal justice partners, and peer specialists with lived experience. Additionally, the legislation authorizes funding for a study by the National Academies to evaluate the program's effectiveness and develop guidelines for scaling it up.
The Examining Opioid Treatment Infrastructure Act of 2026 directs the Comptroller General of the United States to conduct a study on the nation's capacity for treating opioid-use disorders. This evaluation will assess the availability of inpatient and outpatient programs, including detoxification, stabilization, and rehabilitation services, with specific attention to geographic gaps and needs for specific demographics like pregnant women and American Indians. The report will also examine the use of evidence-based treatments and identify barriers to reporting real-time overdose data. Ultimately, the bill aims to provide Congress with a comprehensive overview of current treatment resources and challenges within the healthcare system.
This bill strengthens the enforcement of mental health and substance use disorder parity rules under the Employee Retirement Income Security Act of 1974. It expands the scope of penalties to include plan sponsors, service providers, and administrators who fail to meet existing parity requirements, while also adding a specific category for genetic information violations. To support these enforcement efforts, the legislation appropriates $30 million annually from 2027 through 2031 to the Employee Benefits Security Administration. These changes apply to group health plans starting one year after the law is enacted.
The Medicaid RAC Improvement Act of 2026 strengthens oversight of the Medicaid Recovery Audit Contractor program to improve how states identify and recover improper payments. It requires the Centers for Medicare and Medicaid Services to establish clear expiration dates for state exceptions to the program, mandate detailed annual reports on audit results, and ensure managed care organizations are included in these reviews. Additionally, the bill directs the agency to study barriers preventing states from participating and to launch a five-year demonstration project aimed at increasing state engagement. The legislation also extends the standard audit period to allow reviews of payments made over the previous four fiscal years.
